REFERENCES
1 E
Shaffer, R Hundal. Gallbladder cancer: epidemiology and outcome.Clin Epidemiol 2014;1(6):99-109.
2 K
Gafoor, S Patel, F Girvin, et al. Cavitary Lung Diseases. Chest2018;153(6):1443-65.
3 TA
Aloia, N Járufe, M Javle, et al. Gallbladder Cancer: expert consensus
statement. Hpb (Oxford) 2015;17(8):681-90.
4 Z
Yin, T Chen, Y Shu, et al. A Gallbladder Cancer Survival Prediction
Model Based on Multimodal Fusion Analysis. Dig Dis Sci2023;68(5):1762-76.
5 B
Yuan, X Zhao, X Wang, et al. Patient‐derived organoids for personalized
gallbladder cancer modelling and drug screening. Clin Transl Med2022;12(1): e678.
6 JA
Wernberg, DD Lucarelli. Gallbladder Cancer. Surg Clin North Am2014;94(2):343-60.
7 LB
Gadkowski, JE Stout. Cavitary Pulmonary Disease. Clin Microbiol
Rev 2008;21(2):305-33.
8 A
Canan, K Batra, SS Saboo, M Landay, A Kandathil. Radiological approach
to cavitary lung lesions. Postgrad Med J 2021;97(1150):521-31.
9 H
Malhi, GJ Gores. Cholangiocarcinoma: Modern advances in understanding a
deadly old disease. J Hepatol 2006;45(6):856-67.
10 N
Rout, S Hota, S Dash, et al. Diagnostic utility of ultrasound-guided
fine-needle aspiration cytology in gall bladder lesions: an experience
from a tertiary care cancer center in Eastern India. J Cytol2021;38(3):145.
11 ID
Nagtegaal, RD Odze, D Klimstra, et al. The 2019 WHO classification of
tumours of the digestive system. Histopathology2019;76(2):182-88.
12 MB
Amin, FL Greene, SB Edge, et al. The Eighth Edition AJCC Cancer Staging
Manual: Continuing to build a bridge from a population-based to a more
”personalized” approach to cancer staging. Ca Cancer J Clin2017;67(2):93-99.